|
Today's Headlines
Diabetic patients with ovarian cancer who took the drug metformin for their diabetes had a better survival rate than patients who did not take it, according to a study from Mayo Clinic, published early online in Cancer. » Full article
|
|
Heparin container and carton labels must now clearly state the total drug strength, according to an FDA Drug Safety Communication. » Full article
|
|
Medical use of probiotics could be significant in minimizing Clostridium difficile infection among hospitalized patients taking antibiotics, according to a study published in Annals of Internal Medicine. » Full article
|
|
Osteoporosis medication is also effective in men, according to a large-scale, international study, published in a recent issue of the New England Journal of Medicine. » Full article
|
|
CONTINUING EDUCATION
Welcome to the fourth activity of our CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 credits from September 2012-March 2013 with 7 monthly knowledge-based activities. The December activity will cover insulin therapy for diabetes care management.
To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.
Coming soon - All users will be required to provide their NABP e-Profile ID when logging into the Drug Topics' FREE CPE. This new process requires all pharmacists and pharmacy technicians to provide their NABP e-Profile ID prior to accessing the system. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.
|
|
EDITOR'S PICK
The world of formulary management is changing. More than 80% of all prescribed medications are now generic, and the industry has moved to a new value-based reimbursement strategy. Health plans must find more effective ways of communicating with their affiliated physicians so that best practices are quickly adopted and overall goals of accountable and high-quality care are both understood and reached. To meet the challenges of the new environment, provider education regarding the appropriate formulary decisions needs to be more proactive and collaborative, ensuring that clinicians are truly engaged and understand all P&T decisions. Recognizing the limitations of traditional education programs, the healthcare industry is beginning to appreciate the value of new, innovative and often technology enabled approaches. Formulary teams must help their organizations meet the challenges of the marketplace by becoming more involved in developing and supporting education initiatives and by seeking new ways to educate and engage providers.
» Full article
|
|
|
Like
Tweet
